Regnum Corp.
RGMP
Rank in Stocks
#34825
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$2.29K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Regnum Corp. (RGMP)
Category
Healthcare
EPS for Regnum Corp. (RGMP)
EPS as of March 2023 TTM: $-0.03
According to Regnum Corp.'s latest financial reports, its current EPS (TTM) is $-0.03. At the end of 2022 the company had an EPS of $-0.03, a decrease compared to its 2021 EPS of $-0.01.
EPS history for Regnum Corp. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.03 | 10.00% |
| 2022 | $-0.03 | 193.10% |
| 2021 | $-0.01 | 132.00% |
| 2020 | $-0.01 | 212.50% |
| 2019 | 0.00 | -1,700.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -47,554.55% |
US
|
|
| $-7.07 | 21,324.24% |
US
|
|
| $-5.29 | 15,930.30% |
AU
|
|
| $12.88 | -39,130.61% |
BE
|
|
| $21.56 | -65,433.33% |
NL
|
Questions about Regnum Corp.'s earnings per share (EPS)
What is Regnum Corp.'s earnings per share (EPS)?
Regnum Corp.'s earnings per share (EPS) over the last twelve months is $-0.03, as of Mar 2023.
What was Regnum Corp.'s earnings per share (EPS) in 2022?
In 2022, Regnum Corp.'s earnings per share (EPS) was $-0.03, compared with $-0.01 in 2021.
How has Regnum Corp.'s earnings per share (EPS) changed since 2017?
From 2017 to 2022, Regnum Corp.'s earnings per share (EPS) was highest in 2019 (0.00) and lowest in 2022 ($-0.03).
How does Regnum Corp.'s earnings per share (EPS) compare with similar companies?
Regnum Corp.'s earnings per share (EPS) ($-0.03) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.